MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New imaging agent could spot hidden cancers
Diagnosis Not yet recruitingThis study tests a new radioactive imaging agent called 68Ga-SFB6-ZN01, which is designed to attach to a protein found on many cancer cells. 98 adults with confirmed or suspected cancer will receive a single injection of the agent and then have a PET/CT scan. The goal is to see i…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Ear acupressure: a new weapon against chemotherapy side effects?
Prevention Not yet recruitingThis trial tests whether adding auricular acupressure—using small seed patches on specific ear points—to standard antiemetic medication can better prevent nausea and vomiting in people receiving highly emetogenic chemotherapy. About 332 patients with solid tumors will be randomly…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: NA • Sponsor: China Medical University, China • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
New injection aims to fight Cancer-Related wasting
Symptom relief Not yet recruitingThis study tests a new drug called INB301 in people with cancer who are losing weight and muscle (cancer cachexia). The goal is to see if it is safe and can help patients gain or maintain weight. About 146 adults with solid tumors like lung, pancreatic, or colorectal cancer will …
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Yunnan Baiyao Group Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Healthy volunteers needed to test new version of cancer drug
Knowledge-focused Not yet recruitingThis early-stage study tests a new formulation of the cancer drug HRS-2189 in 28 healthy adults aged 18-45. The goal is to compare how the body absorbs the new versus the old tablet version and to check for safety. Participants will take a single dose of each formulation in rando…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC